INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 31, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Jul 27, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 4,639 |
| Oct 01, 2008 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Other acquisition or disposition | -- | -- | 4,275 |
| Feb 27, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 1 | $462.15 | 11,887 |
| Apr 23, 2007 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 1 | $25.49 | 14,743 |
| Apr 14, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 2 | $517.99 | 16,875 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 9 | $17.55 | 3,855 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 14 | $17.04 | 4,259 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 15 | $16.89 | 4,856 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $16.88 | 4,839 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.